Literature DB >> 7037510

Lack of glucagon response in glucose counter-regulation in type 1 (insulin-dependent) diabetics: absence of recovery after prolonged optimal insulin therapy.

G Bolli, G Calabrese, P De Feo, P Compagnucci, G Zega, G Angeletti, M G Cartechini, F Santeusanio, P Brunetti.   

Abstract

Mild hypoglycaemia was induced using an artificial pancreas in five normal subjects (from 5.00 +/- 0.15 to 2.83 +/- 0.15 mmol/l) by infusing 28 mU/m2 per min soluble insulin for 60 min. Six Type 1 (insulin-dependent) diabetic patients were stabilized for 14h using an artificial pancreas. They were then rendered hypoglycaemic (from 4.94 +/- 0.09 to 2.89 +/- 0.11 mmol/l) by infusing 28 mU/m2 per min plus 16 +/- 3.8 mU/min insulin for 60 min. Before the study, the diabetic patients were in optimal blood glucose control (mean blood glucose 6.72 +/- 0.11 mmol/l over the previous 14-20 days; HbA1 8.3 +/- 0.1%). During the insulin infusion test, blood glucose decrement was slower in the diabetic patients than in the control subjects. The blood glucose nadir was delayed in the diabetics until 75 min compared with 55 min in the control subjects. Blood glucose recovery rate in the diabetic subjects was severely impaired. In Type 1 diabetes, the counter-regulatory hormonal response to insulin induced hypoglycaemia is similar to that of non-diabetics, except for that of glucagon, the blunted response of which is not reversed by prolonged optimisation of blood glucose control. This impaired response of the A cell does not seem to be a consequence of insulin deficiency.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037510     DOI: 10.1007/bf00254837

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump.

Authors:  W V Tamborlane; R S Sherwin; V Koivisto; R Hendler; M Genel; P Felig
Journal:  Diabetes       Date:  1979-08       Impact factor: 9.461

3.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

Review 4.  Glucagon physiology and pathophysiology.

Authors:  R H Unger
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

5.  Glucagon response to hypoglycemia in sympathectomized man.

Authors:  J P Palmer; D P Henry; J W Benson; D G Johnson; J W Ensinck
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

6.  Neural control of counter-regulatory events during glucopenia in man.

Authors:  R G Brodows; F X Pi-Sunyer; R G Campbell
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.

Authors:  L V Campbell; E W Kraegen; L Lazarus
Journal:  Br Med J       Date:  1977-12-10

8.  Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.

Authors:  J C Pickup; H Keen; J A Parsons; K G Alberti; A S Rowe
Journal:  Lancet       Date:  1979-06-16       Impact factor: 79.321

9.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

10.  Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring.

Authors:  J D Mackay; M M Page; J Cambridge; P J Watkins
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

View more
  12 in total

Review 1.  Insulin treatment: a non-stop revolution.

Authors:  J Mirouze
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

2.  Glucagon-reactive islet-infiltrating CD8 T cells in NOD mice.

Authors:  Gayatri Mukherjee; Rodolfo J Chaparro; Jennifer Schloss; Carla Smith; Christopher D Bando; Teresa P DiLorenzo
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

3.  GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.

Authors:  Nina Xiaoyan Li; Stacey Brown; Tim Kowalski; Margaret Wu; Liming Yang; Ge Dai; Aleksandr Petrov; Yuyan Ding; Tamara Dlugos; Harold B Wood; Liangsu Wang; Mark Erion; Robert Sherwin; David E Kelley
Journal:  Diabetes       Date:  2018-04-18       Impact factor: 9.461

4.  Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts.

Authors:  P Diem; J B Redmon; M Abid; A Moran; D E Sutherland; J B Halter; R P Robertson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Hypoglycemia in diabetes among children and adolescents.

Authors:  M M Karp
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

6.  Effects of chronic sodium salicylate feeding on the impaired glucagon and epinephrine responses to insulin-induced hypoglycaemia in streptozotocin diabetic rats.

Authors:  D G Patel; K A Skau
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

7.  Counterregulatory hormone release after human and porcine insulin in healthy subjects and patients with pituitary disorders.

Authors:  M M Landgraf-Leurs; I Brügelmann; S Kammerer; R Lorenz; R Landgraf
Journal:  Klin Wochenschr       Date:  1984-07-16

8.  Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.

Authors:  I Lager; H von Schenck; U Smith
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

9.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; P Compagnucci; F Santeusanio; P Brunetti; R H Unger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Quantitative measurement of islet glucagon response to hypoglycemia by confocal fluorescence imaging in diabetic rats: effects of phlorizin treatment.

Authors:  K S Rastogi; R L Cooper; Z Q Shi; M Vranic
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.